Groundbreaking research about long term contin... - CLL Support
Groundbreaking research about long term continuous venetoclax therapy for chronic lymphocytic leukaemia
You need to be a member of this community to see this post.
20 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
2025 Update about Chronic Lymphocytic Leukemia, its epidemiology, pathogenesis, diagnosis and therapy
The American Journal of Hematology has published German CLL specialist Michael Hallek's 2025 update...
Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell CLL
Chronic Lymphocytic Leukaemia (CLL) is associated with immune suppression and susceptibility to...
BTK Degrader Shows Potential for Treating Refractory CLL and SLL
A novel Bruton's tyrosine kinase (BTK) degrader, NX-2127, has shown potential for treating patients...
Growth dynamics in naturally progressing chronic lymphocytic leukaemia
Abstract from Nature, 29/5/19 - Unfortunately the whole article is behind a paywall.
"We used...
Encouraging results from venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
We've heard that re-treatment with venetoclax is possible. Per the attached image, here's some...
Related Posts
- Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Update on The CLARITY Study
- Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
- Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia
- Breakthrough in laboratory production of red blood cells towards saving lives of those with Chronic Lymphocytic Leukaemia in the future
- Real-world incidence and prevention of tumor lysis syndrome (TLS) in chronic lymphocytic leukemia (CLL) treated with venetoclax. From MSK
